ArticleRevista brasileira de hematologia e hemoterapia
Mortality by sickle cell disease in Brazil.
Article in Revista brasileira de hematologia e hemoterapia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Mortality trends and socioeconomic inequalities in sickle cell disease in Colombia, 2012-2023: a population-based study.Orphanet journal of rare diseases · 2026Article
- Mortality from sickle cell disease in Brazil.PLOS global public health · 2025Article
- Epidemiological characterization of rare diseases in Brazil: A retrospective study of the Brazilian Rare Diseases Network.Orphanet journal of rare diseases · 2024Article
- Sleep experiences of parents of children 18 years or younger with sickle cell disease during the COVID-19 pandemic: a qualitative study.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2024Article
- Mortality trends and sociodemographic factors associated with early death in sickle cell disease patients in the state of São Paulo.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2024Article
- Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence.Blood advances · 2023Article
- Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country.BMC health services research · 2022Article
- Economic burden of sickle cell disease in Brazil.PloS one · 2022Article
- Clinical-Epidemiological Characteristics and Mortality in Patients with Sickle Cell Anemia: A Retrospective Cohort Study of 1980 at 2018.International journal of general medicine · 2022Article
- Incidence of hemoglobinopathies and spatialization of newborns with sickle cell trait in Mato Grosso do Sul, Brazil.Einstein (Sao Paulo, Brazil) · 2022Article
- Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000-2019.Revista de saude publica · 2022Article
- Diagnosing sickle cell disease and iron deficiency anemia in human blood by Raman spectroscopy.Lasers in medical science · 2020Article
- Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function.Einstein (Sao Paulo, Brazil) · 2020Article
- SPATIAL DISTRIBUTION OF NEWBORNS WITH SICKLE CELL TRAIT IN SERGIPE, BRAZIL.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2020Article
- Interaction between hemoglobin S and N-Baltimore: a case report in Pernambuco, Brazil.Hematology, transfusion and cell therapyArticle
- Sickle cell disease related mortality in Brazil, 2000-2018.Hematology, transfusion and cell therapyArticle
- Updating the Brazilian clinical practice guidelines for sickle cell disease: Recommendations and development process.Hematology, transfusion and cell therapyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work aimed to characterize mortality by sickle cell disease in Brazil. The MEDLINE electronic database was searched using the terms 'mortality' and 'sickle cell disease' and 'Brazil' for articles published in the last five years aiming to provide a current analysis of the subject in question. Eight studies on mortality by sickle cell disease were carried out in the Brazilian states of Maranhão, Bahia, Minas Gerais, Rio de Janeiro and Mato Grosso do Sul. The majority of the deaths occurred in patients with sickle cell anemia, which is the most common genotype and causes the most severe clinical manifestation of the disease. In summary, there are few published studies on mortality related to sickle cell disease in Brazil, and most are from the state of Minas Gerais. This study emphasizes the importance of developing more studies on sickle cell disease mortality, so that it may be possible to profile gene carriers and give health professionals more data to strategize the delivery of more effective assistance to these individuals. Despite the early diagnosis of sickle cell disease by the Neonatal Screening Program and the use of preventive and therapeutic measures (penicillin, immunization and hydroxyurea), mortality by sickle cell disease on the world stage is still significant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.